About American Fork Hospital / Huntsman Intermountain Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at American Fork Hospital / Huntsman Intermountain Cancer Center
During the past decade, American Fork Hospital / Huntsman Intermountain Cancer Center conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 38 clinical trials were completed, i.e. on
average, 64.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 24 clinical trials were completed. i.e. 800%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
2006-02-09
2011-03-15
Completed
118
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
2006-08-11
2016-12-15
Completed
60
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
2006-09-15
2014-07-02
Completed
295
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
2007-01-24
2018-09-04
Completed
64
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "American Fork Hospital / Huntsman Intermountain Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 18 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology"
with 9 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "American Fork Hospital / Huntsman Intermountain Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at American Fork Hospital / Huntsman Intermountain Cancer Center
According to Clinical.Site data, the most researched conditions in "American Fork Hospital / Huntsman Intermountain Cancer Center" are
"Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Carcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials) and "HER2/Neu Negative" (4 trials). Many other conditions were trialed in "American Fork Hospital / Huntsman Intermountain Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at American Fork Hospital / Huntsman Intermountain Cancer Center
Most popular intervention types in "American Fork Hospital / Huntsman Intermountain Cancer Center" are "Other" (81 trials), "Drug" (77 trials), "Biological" (46 trials), "Procedure" (32 trials) and "Radiation" (24 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (35 trials), "Questionnaire Administration" (19 trials), "Biospecimen Collection" (15 trials) and "Computed Tomography" (15 trials). Other intervention names were less common.
Clinical Trials Genders at American Fork Hospital / Huntsman Intermountain Cancer Center
The vast majority of trials in "American Fork Hospital / Huntsman Intermountain Cancer Center" are
80 trials for "All" genders, 21 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at American Fork Hospital / Huntsman Intermountain Cancer Center
Currently, there are NaN active trials in "American Fork Hospital / Huntsman Intermountain Cancer Center".
undefined are not yet recruiting,
19 are recruiting,
59 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in American Fork Hospital / Huntsman Intermountain Cancer Center,
3 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in American Fork Hospital / Huntsman Intermountain Cancer Center, 2 "Phase 1"
clinical trials were conducted, 43 "Phase 2" clinical
trials and 66 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".